Peru R.M. N° 283-98-SA/DM IVD Classification List: Three-Layer Lookup and 2026 Practice

Regulatory information verified as of October 29, 2026

1. Key takeaways

Looking up the classification of an IVD in Peru requires pulling three layers of text at once: the parent list R.M. N° 283-98-SA/DM, published on 1998-08-07, plus the first amendment R.D. N° 1137-2003-DG-DIGEMID, published on 2003-09-01, plus the second amendment R.D. N° 1305-2005-DG-DIGEMID, published on 2005-09-16. Consulting the parent list alone necessarily misses the entry adjustments made by the two later amendments, and treating the parent list as the final text is the principal cause of classification misplacement in IVD submissions. The list must be read as a living instrument whose entries have been edited twice, and every citation in a technical file should identify the entry as amended, not as originally enacted, with current status confirmed against DIGEMID publications at the time of each new project.

2. Legal basis

Regulatory information verified as of October 29, 2026.

3. Expert insights

Insight 1: the normative form of the amendments is why the parent list is not the final text.

R.M. N° 283-98-SA/DM is a ministerial resolution (Resolución Ministerial), yet its two amendments were issued as directoral resolutions (Resolución Directoral) — R.D. N° 1137-2003-DG-DIGEMID and R.D. N° 1305-2005-DG-DIGEMID. An issuing level below that of the amended instrument is not contradictory in administrative law: the amendments target specific entries within the list, are technical adjustments at the executive level, and may validly be made by the competent directorate through a directoral resolution. The mechanical meaning for companies is that a lower issuing level does not mean a lower legal effect — taking only the parent list means working with a list that has already been changed twice, and entries may have been added, removed or reworded in ways that alter the classification outcome.

Insight 2: three publications across seven years show that the list is a living instrument.

The parent list was published on 1998-08-07, the first amendment on 2003-09-01 and the second on 2005-09-16, a span of roughly 7 years. That rhythm reflects how the list operates: entries are added and removed as testing technology and product formats evolve, rather than being fixed once. Two conclusions follow. First, any citation must confirm the status of the cited entry in the amended text. Second, we hold no record of amendments after 2005-09-16, which does not mean none exist — the currently effective text follows current DIGEMID publications, and nothing may be inferred to the effect that the list has been unchanged since 2005-09-16.

Insight 3: a function-and-specialty system has natural coverage gaps for novel markers.

R.M. N° 283-98-SA/DM is catalogued by function and professional use, and its entries correspond to established test items and specialty domains. Novel biomarkers, multi-omic panels and companion-diagnostic-type products often cannot be matched to an entry directly. The category Ñ added by D.S. N° 020-2001-SA, published on 2001-07-16, is precisely the trace of such gaps being handled — the system absorbs new products by adding categories rather than rebuilding the list. For a product the list does not cover, the correct action is to request a classification confirmation from DIGEMID and archive the written reply, not to self-classify by nearest neighbor; the specific article numbers for the relevant procedure are pending verification, and official publications prevail.

Insight 4: list entries and labeling duties are linked.

D.S. N° 020-2001-SA requires diagnostic reagents to state specificity and sensitivity on the label. That duty is linked to list classification: the functional domain into which a product falls determines the form of its performance claims and the label elements. If classification is done by nearest-neighbor guesswork, the performance statements on the label will drift away from the actual validation data, and the defect will surface simultaneously in review and in post-market vigilance — R.M. N° 539-2016/MINSA, published on 2016-07-27, requires serious adverse events to be reported within 24 hours, and misdiagnosis events caused by wrong performance statements fall squarely into that reporting line.

4. Practical recommendations

1. Build a three-layer ledger: keep one column each for the parent list and the two amendments, marking every entry as original entry, as amended 2003 and as amended 2005, and cite only the amended text.
2. Cite with instrument numbers: in technical files and application forms, state that the reference is R.M. N° 283-98-SA/DM (1998-08-07) as amended by R.D. N° 1137-2003-DG-DIGEMID (2003-09-01) and R.D. N° 1305-2005-DG-DIGEMID (2005-09-16), never the parent number alone.
3. Confirm before filing novel products: for products not covered by the list, request a classification confirmation from DIGEMID and archive the written reply as the basis for later submission and re-registration (relevant procedural article numbers pending verification; official publications prevail).
4. Check classification and labeling together: once the functional domain is fixed, verify the specificity and sensitivity statements on the label (D.S. N° 020-2001-SA) against the validation report values.
5. Schedule on the IVD clock: the review clock is 30 working days, managed separately from the 22 / 44 / 66 working days of non-IVD devices; total project duration has no statutory basis and we estimate on a practical estimate basis at 3–6 months.
6. Re-verify periodically: the list is a living instrument, so re-check entry status against current DIGEMID publications at the start of every new project.

5. Verification checklist

□ The full text of the parent list R.M. N° 283-98-SA/DM (1998-08-07) has been obtained

□ The amended text of R.D. N° 1137-2003-DG-DIGEMID (2003-09-01) has been obtained and compared entry by entry

□ The amended text of R.D. N° 1305-2005-DG-DIGEMID (2005-09-16) has been obtained and compared entry by entry

□ It has been confirmed that cited entries reflect the state after both amendments, not the original parent list

□ Current DIGEMID publications have been checked for subsequent amendments

□ A classification confirmation has been requested for novel or uncovered products, with the written reply retained

□ Label specificity and sensitivity statements have been checked against the validation report (D.S. N° 020-2001-SA)

□ Scheduling follows the 30 working days clock

Regulatory information verified as of October 29, 2026.

GRZAN Regulatory Team

GRZAN provides registration support in Peru for manufacturers, importers and authorized representatives, including IVD classification research and DIGEMID confirmation requests. Contact: info@grzanglobal.com